European startups
fromSilicon Canals
4 days agoDutch-based Leyden Labs secures 20M from EIB
Leyden Laboratories secures €20M funding to enhance pandemic preparedness through innovative antiviral research.
The focus is on developing non-vaccine therapies for respiratory viruses, specifically a nasal spray targeting influenza.